Prescription drug · ANDA
cyanocobalamin NDC 45802-491
Cyanocobalamin 500 ug/1 · Spray · Nasal · Padagis Israel Pharmaceuticals Ltd
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 45802-491-84 | 45802049184 | 4 BOTTLE, UNIT-DOSE in 1 CARTON (45802-491-84) / 1 SPRAY in 1 BOTTLE, UNIT-DOSEMarketed from Dec 28, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- cyanocobalamin
- Generic name (nonproprietary)
- cyanocobalamin
- Active ingredients
- Cyanocobalamin — 500 ug/1
- Dosage form
- Spray
- Route
- Nasal
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 212458
- Marketing start
- Listing expires
- Other FDA classes
- Vitamin B 12 (Chemical structure)
- Identifiers
- Product ID 45802-491_4cf650d9-6d6c-4112-88f2-cd2e94f1f416SPL ID 4cf650d9-6d6c-4112-88f2-cd2e94f1f416SPL set ID 971e5f30-55c2-4193-9dd8-b43a1862b92aRxCUI 861113UNII P6YC3EG204
- Pharmacologic class
- Vitamin B12
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Nasal products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N445802049184followed by a unit qualifier and the quantityPackage 45802-0491-84. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Cyanocobalamin Nasal Spray is indicated for: • Vitamin B 12 maintenance therapy in adult patients with pernicious anemia who are in remission following intramuscular vitamin B 12 therapy and who have no nervous system involvement • Treatment of adult patients with dietary, drug-induced, or malabsorption-related vitamin B 12 deficiency not due to pernicious anemia • Prevention of vitamin B 12 deficiency in adult patients with vitamin B 12 requirements in excess of normal Limitations of Use • Cyanocobalamin Nasal Spray should not be used for the vitamin B 12 absorption test (Schilling test). • In patients with correctible or temporary causes of vitamin B 12 deficiency, the benefit of continued…
Excerpt only. Read the full label for complete information.